SAB Biotherapeutics, Inc. (SABS)
NASDAQ·Healthcare·Biotechnology
$3.52
+1.30%
Mkt Cap $33.17M
Next Earnings
In 9 daysThu, May 7, 2026
EPS Estimate
-$0.73
3 analysts
Revenue Estimate
$333.33K
Last quarter: missed by -187.50% on EPS.
EPS — Estimate vs Actual
Mkt Cap
$33.17M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.67